Assessing Tissue Viability with StO2

Enables Early Intervention to Improve Patient Outcomes.

Company Overview

ViOptix, Inc. gives clinicians a revolutionary new capability — to obtain non-invasive, objective, real-time measurement of oxygen saturation (StO2) in the soft tissues affected by breast reconstruction and other surgical procedures – to help improve patient surgical outcomes by detecting problems before symptoms are visible.

Questions? Let’s Talk.

Call: 510-226-5860


  • Hidden
  • This field is for validation purposes and should be left unchanged.